Clinical Interventions in Aging

Clinical Interventions in Aging is published by Dove Medical Press Ltd. and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Frailty in Older Adults, Nutrition and Health in Aging and Dementia and Cognitive Impairment Research, together about 32.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Editor-in-Chief: Professor Nandu Goswami Clinical Interventions in Aging focuses on concise and rapid reporting of original research and reviews in aging. Special attention will be given to papers focused on prevention or treatment of diseases in older persons (> 65 years) or a greater understanding of patho (physio-) logical processes that result from maladaptive changes in the body associated with aging. Clinical Interventions in Aging will no longer accept meta-analyses, perspectives, and study protocols for publication. Specific topics covered by the journal include: Intrinsic diseases of aging such as cancer, diabetes, dementia, etc. Management of “normal” but degenerative aging processes such as changes in body composition leading to the loss of independence and decreased quality of life Functional and cognitive decline in humans Falls and falls-related injuries risk, assessment and interventions in older persons Health-oriented approach to aging (as opposed to a disease-oriented one) Integrative, preventive, and personalized approaches in aging care Replacement of essential substances whose concentrations decline during aging Clinical options to combat the maladaptive effects of aging Preventing or delaying the onset of intrinsic diseases of aging Managing functional decline during senescence Metabolic therapies Indicators of disease risk Health systems or structures that support scaling approaches in aging healthcare and health care interventions Submissions to Clinical Interventions in Aging should have a clear aging research focus, with a particular focus on older persons (> 65 years). Only in exceptional cases will manuscripts that are related to early onset diseases will be considered (e.g., Alzheimer’s). The journal welcomes submitted papers covering original research, epidemiological studies, reviews, expert opinions, and commentaries. Pre-clinical studies in healthy persons which help in understanding aging related functional and cognitive decline and falls risk are also welcome. However, animal and cell-based studies will not be considered. When considering submission of a paper utilizing publicly available data, authors should ensure that such studies add significantly to the body of knowledge and that they are validated using the authors’ own data through replication in an original sample. Case reports/series submitted to Clinical Interventions in Aging will be diverted to the case reports section of the International Medical Case Reports

From the journal's Aims & Scope

Research area (LetPub): GERIATRICS & GERONTOLOGY

Editor-in-chief Nandu GoswamiPublisher website

Editorial board by country: 7 in mainland China (about 11%); most named Mainland China 7, Austria 6, United States 4, United Kingdom 4, Türkiye 4 (64 members with a country) Editorial board ↗Publisher website · 2026-09-29

CAS Journal Ranking

JCR / CiteScore quartiles on the journal's website

• JCR Q2 · best quartile · 2025
• CiteScore Q2 · 2025

Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website

Database indexing

SCIEScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Impact

Impact factor

4.07LetPub · 2026-09-13

Impact factor (publisher) 2025

4.5Publisher website · 2026-09-29

5-year impact factor (publisher)

6Publisher website · 2026-09-29

CiteScore 2026-06

6LetPub · 2026-09-13

CiteScore (publisher) 2025

1.27Publisher website · 2026-09-29

SJR 2026-06

1.11LetPub · 2026-09-13

SNIP 2026-06

1.27LetPub · 2026-09-13

h-index

59LetPub · 2026-09-13

h-index

138OpenAlex · 2026-10-01

i10-index

2,170OpenAlex · 2026-10-01

2-year mean citedness

3.71OpenAlex · 2026-10-01

Self-citation rate

0%LetPub · 2026-09-13

Share of gold OA articles

98.93%LetPub · 2026-09-13

Volume

Articles per year

207LetPub · 2026-09-13

Downloads per year (publisher)

368,078Publisher website · 2026-09-29

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Other sources

Average review time (community reports)

6–12 weeksLetPub · 2026-09-13

Average acceptance (community reports)

Fairly easyLetPub · 2026-09-13

Acceptance rate (publisher)

6%Publisher website · 2026-09-29

Desk decision

51 daysPublisher website · 2026-09-29

Peer review

Anonymous peer reviewLetPub

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Publisher

Dove Medical Press Ltd.

Country or region

NEW ZEALAND

Language

English

Founded

2006

ISSN

1176-9092

Electronic ISSN

1178-1998

Official links

• Journal homepage ↗OpenAlex
• Submission system ↗LetPub
• Author guidelines ↗LetPub
• Aims & Scope ↗LetPub
• Special issues ↗Publisher website
• Peer review process ↗LetPub
• Editorial board ↗LetPub